Virtual Medicinal Product (VMP)
-
Estradiol 50mg implant
Name Details
Current Name
Estradiol 50mg implant
|
Start Date
31-01-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- device
- Unit Dose UOM
- device
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Prolonged-release subcutaneous implant
- Ontology Form/Route
- implant.subcutaneous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03CA03
BNF |
Current BNF
06040101
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040101
|
Start Date
23-02-2005
|
End Date
24-05-2012
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41875511000001108 |
26-05-2023 |
|
325541008 |
31-01-2003 |
25-05-2023 |
VMP Ingredients
VMP ingredients table
Estradiol |
Based on Ingredient Substance |
|
50 mg |
|
Name
Estradiol
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTM
Estradiol
-
VMP
(Current) Estradiol 50mg implant
Virtual Medicinal Product Pack (VMPP) Information